The shares of Asian pharmaceutical companies fell on Friday after US President Donald Trump announced new customs on furniture, heavy trucks and pharmaceutical products.
Starting from 1. October, “Each branded or patented pharmaceutical product” faces 100% customs, except firms that build drives to produce drugs in the USA, Trump told Truth Social early on Friday.
The topix pharma index fell by 1.47% after the post. Daiichi Sankyo and Chugai Pharmaceutical were among the companies that led losses, with a drop of 2.11% and 3.64%, respectively. Sumitomo Pharma extended losses, fell by 5.33%.
Heavy South Korean pharmaceutical companies such as Samsung Biologics and SK Bio Pharmaceuticals fell by 1.71% and 3.71%.
Pharmaceutical firms listed on the Hong Kong stock market also fell. Alibaba Health Information Technology and JD Health were also among the largest losers, with a drop of 2.92% and 2.23%, respectively.
In a separate announcement on Truth Social, Trump said that the import of heavy trucks will be subjected to a customs of 25%. Meanwhile, kitchen cabinets, bathroom cabinets and “connected products” will face a 50% customs, while the customs of 30% will be charged on upholstered furniture.
Overnight in the US, Trump also signed the Executive Regulation approving the proposal that would maintain a tictional on life in the United States. The transaction assesses business at $ 14 billion, according to the Vice President JD Vance.
According to the conditions, which of China must be approved, the new joint firm will monitor the Tictionary business in the United States, and bytedance will retain less than 20% of the share, SEEbiz reports.
Japanese Nikkei 225 was unchanged, while Topix rose by 0.59% and reached a new record maximum. Investors also estimated information on inflation from September in the Japanese capital to Tokyo.
The core inflation in the city was milder than expected, with 2.5%, compared to expectations of 2.8% of the economists interviewed by Reuters. Total inflation remained stable at 2.5%. Inflation data in Tokyo is generally considered a leading indicator of national trends.
South Korean Kospa fell 2.02%, losing losses in Asia, while the KosdaQ withdraws with a small market capitalization by 1.57%.
Australian S & P / ASX 200 was slightly under stagnation.
Hong Kong Hang Seng Index dropped by 0.86%, while the CSI index is on the mainland of China remained stagnant.
